## Overview of FDA Approval Calendars
FDA approval calendars are tools used to track key regulatory dates relating to drug and biologic approvals in the United States. They are widely utilized by biotechnology and pharmaceutical companies, investors, and healthcare professionals to monitor upcoming U.S. Food and Drug Administration (FDA) decisions, scheduled advisory committee meetings, and milestones such as Prescription Drug User Fee Act (PDUFA) dates.
## Major FDA Approval Calendar Resources
Several platforms provide FDA approval calendars with varying features:
**FDA Tracker**
– Tracks upcoming PDUFA drug approval dates and FDA advisory committee meetings.
– Offers both a standard and enhanced calendar, with features like integration of PDUFA dates, clinical trial completion timelines, and financial runway estimates for publicly traded companies[1].
**BioPharmCatalyst**
– Updates daily with future FDA-related catalysts for biotech and pharma companies.
– Features include PDUFA dates, advisory committee meetings, and important regulatory milestones[2].
**Benzinga FDA Calendar**
– Provides up-to-date calendars listing scheduled FDA actions, PDUFA dates, advisory committee meetings, and decision outcomes (approval, complete response, or delays).
– Summarizes application types (e.g., NDA, BLA, sNDA, sBLA) and expected review durations (standard: 10 months, priority: 6 months)[5].
**CheckRare Orphan Drug Calendar**
– Focuses on PDUFA and other regulatory dates specifically for orphan drugs, offering a list of key approval deadlines for 2025[4].
**FDA Official Website (NDA and BLA Approvals)**
– Publishes annual reports listing approved New Molecular Entities (NMEs) and Biologic License Applications (BLAs) with priority and efficacy supplement approvals[3].
## Key Features Often Included
– **PDUFA dates**: Statutory deadlines for FDA to review and make decisions on drug and biologic applications.
– **Advisory committee meetings**: Scheduled discussions with external experts that often precede major approval decisions.
– **FDA Decisions**: Outcomes such as approval, complete response letter, or delay.
– **Special designations**: Information about orphan drug status, rare disease indication, accelerated approval, priority review, and more.
– **Other milestones**: Including clinical trial readouts and key data presentations[1][2][4][5].
## How to Access
– Publicly available calendars such as those from BioPharmCatalyst and Benzinga can be accessed online without an account[2][5].
– Some platforms, like FDA Tracker, offer enhanced calendar features requiring user registration or subscription[1].
– The FDA’s own website offers annual approval lists, suited for reference rather than forward-looking tracking[3].
## Example Uses
– Tracking when new drugs might receive FDA decisions.
– Monitoring high-impact catalysts for biotech investors.
– Planning regulatory strategy in pharmaceutical development.
## Summary Table: Comparison of FDA Calendar Resources
| Calendar Provider | Key Features | Focus Area | Accessibility |
|———————–|————————————————————————|————————|——————–|
| FDA Tracker | PDUFA dates, advisory meetings, clinical timeline, financial runway | Publicly traded firms | Basic/Enhanced |
| BioPharmCatalyst | PDUFA, committee meetings, daily updates | Biotech/pharma | Free/Premium |
| Benzinga | Full FDA action schedule, decisions, multi-application types | Broad (U.S./Global) | Free |
| CheckRare | Orphan drug focus, PDUFA and approval dates | Orphan drugs | Free |
| FDA (official site) | Historical NDA/BLA approvals, annual reports | Approvals (not future) | Free |
These calendars are invaluable for anyone looking to keep up with important upcoming FDA actions and drug approval decisions. For the most comprehensive view, it is advisable to consult multiple sources[1][2][5].